DEARhealth

DEARhealth is a Dutch-American healthcare spin-out from the University of California, Los Angeles (UCLA), founded in 2013 by gastroenterologists Daniel Hommes and Eric Esrailian.

DEARhealth
TypePrivate
IndustryHealthcare
FoundedLos Angeles, California, United States (2013)[1]
FounderDaniel Hommes
Eric Esrailian[2]
Headquarters
Los Angeles, California; Amsterdam
,
United States, The Netherlands
Key people
Daniel Hommes (co-Founder and CEO), Alberto Montilla (CTO), Aria Zand (CPO), Reender Beks (CFO), Katinka de Korte (General Manager Europe)
Websitedearhealth.com

The company develops artificial intelligence-powered, personalized care pathways for chronic care.[3] The platform supports Value Based Health Care and aims to get the best outcomes for patients and providers, optimizing a value quotient (vQ), defined as patient value/provider costs.[4] Treatment areas include inflammatory bowel disease, pain management, liver diseases, ovarian cancer, chronic kidney diseases, low back pain and epilepsy.[5]

History

In 2012 DEARhealth started as a research project at UCLA. In 2013 DEARhealth was founded as a company. In June 2019 DEARhealth announced collaboration outside UCLA with UCB on epilepsy.[6] In July 2019, the company closed a series A funding round led by Philips.[7]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.